Search Results - "MORRIS, Meghan D"

Refine Results
  1. 1

    Progress toward closing gaps in the hepatitis C virus cascade of care for people who inject drugs in San Francisco by Mirzazadeh, Ali, Chen, Yea-Hung, Lin, Jess, Burk, Katie, Wilson, Erin C, Miller, Desmond, Veloso, Danielle, McFarland, Willi, Morris, Meghan D

    Published in PloS one (02-04-2021)
    “…People who inject drugs (PWID) are disproportionately affected by hepatitis C virus (HCV). Data tracking the engagement of PWID in the continuum of HCV care…”
    Get full text
    Journal Article
  2. 2

    Hepatitis C prevalence and key population size estimate updates in San Francisco: 2015 to 2019 by Facente, Shelley N, Grinstein, Rachel, Bruhn, Roberta, Kaidarova, Zhanna, Wilson, Erin, Hecht, Jennifer, Burk, Katie, Grebe, Eduard, Morris, Meghan D

    Published in PloS one (11-05-2022)
    “…In 2017, San Francisco's initiative to locally eliminate hepatitis C virus (HCV) as a public health threat, End Hep C SF, generated an estimate of city-wide…”
    Get full text
    Journal Article
  3. 3

    HCV incidence is associated with injecting partner age and HCV serostatus mixing in young adults who inject drugs in San Francisco by Page, Kimberly, Evans, Jennifer L, Hahn, Judith A, Vickerman, Peter, Shiboski, Stephen, Morris, Meghan D

    Published in PloS one (10-12-2019)
    “…HCV incidence is increasing in the US, notably among younger people who inject drugs (PWID). In a cohort of young adult (age<30 years) PWID in San Francisco we…”
    Get full text
    Journal Article
  4. 4

    Injecting-related trust, cooperation, intimacy, and power as key factors influencing risk perception among drug injecting partnerships by Morris, Meghan D, Andrew, Erin, Tan, Judy Y, Maher, Lisa, Hoff, Colleen, Darbes, Lynae, Page, Kimberly

    Published in PloS one (31-05-2019)
    “…Sharing of injection drug use paraphernalia is a dyadic process linked to the transmission of HIV and hepatitis C virus (HCV). Despite this, limited research…”
    Get full text
    Journal Article
  5. 5

    Estimated hepatitis C prevalence and key population sizes in San Francisco: A foundation for elimination by Facente, Shelley N, Grebe, Eduard, Burk, Katie, Morris, Meghan D, Murphy, Edward L, Mirzazadeh, Ali, Smith, Aaron A, Sanchez, Melissa A, Evans, Jennifer L, Nishimura, Amy, Raymond, Henry F

    Published in PloS one (11-04-2018)
    “…Initiated in 2016, End Hep C SF is a comprehensive initiative to eliminate hepatitis C (HCV) infection in San Francisco. The introduction of direct-acting…”
    Get full text
    Journal Article
  6. 6

    Intimate injection partnerships are at elevated risk of high-risk injecting: a multi-level longitudinal study of HCV-serodiscordant injection partnerships in San Francisco, CA by Morris, Meghan D, Evans, Jennifer, Montgomery, Martha, Yu, Michelle, Briceno, Alya, Page, Kimberly, Hahn, Judith A

    Published in PloS one (06-10-2014)
    “…It is increasingly recognized that the risk for HIV and hepatitis C (HCV) transmission among people who inject drugs (PWID), such as syringe sharing, occurs in…”
    Get full text
    Journal Article
  7. 7

    Staff-Facilitated Telemedicine Care Delivery for Treatment of Hepatitis C Infection among People Who Inject Drugs by Kim, Rebecca G, McDonell, Claire, McKinney, Jeff, Catalli, Lisa, Price, Jennifer C, Morris, Meghan D

    Published in Healthcare (Basel) (01-04-2024)
    “…Telemedicine offers the opportunity to provide clinical services remotely, thereby bridging geographic distances for people engaged in the medical system…”
    Get full text
    Journal Article
  8. 8
  9. 9
  10. 10
  11. 11
  12. 12

    Injection Drug Use and Hepatitis C Virus Infection in Young Adult Injectors: Using Evidence to Inform Comprehensive Prevention by Page, Kimberly, Morris, Meghan D., Hahn, Judith A., Maher, Lisa, Prins, Maria

    Published in Clinical infectious diseases (15-08-2013)
    “…The hepatitis C virus (HCV) virus epidemic is ongoing in the United States and globally. Incidence rates remain high, especially in young adult injection drug…”
    Get full text
    Journal Article
  13. 13
  14. 14
  15. 15

    Low-income San Franciscans' Access to Basic Needs during COVID Shelter-in-Place: A Focus on People Who Use Drugs by McDonell, Claire, Li, Rocky, Runnels, Anya, Morris, Meghan D

    “…We conducted a cross-sectional study of low-income San Franciscans to assess the impact of COVID-19 on their life and well-being during the period of the…”
    Get more information
    Journal Article
  16. 16
  17. 17

    Treatment cascade for hepatitis C virus in young adult people who inject drugs in San Francisco: Low number treated by Morris, Meghan D., Mirzazadeh, Ali, Evans, Jennifer L., Briceno, Alya, Coffin, Phillip, Hahn, Judith A., Page, Kimberly A.

    Published in Drug and alcohol dependence (01-05-2019)
    “…•While only half accepted a treatment referral, all 5 who started therapy achieved SVR. To understand the number of young adult people who inject drugs (PWID)…”
    Get full text
    Journal Article
  18. 18

    Racial/Ethnic Disparities in Arrests for Drug Possession After California Proposition 47, 2011-2016 by Mooney, Alyssa C, Giannella, Eric, Glymour, M Maria, Neilands, Torsten B, Morris, Meghan D, Tulsky, Jacqueline, Sudhinaraset, May

    Published in American journal of public health (1971) (01-08-2018)
    “…To evaluate the effects of California Proposition 47, which reclassified felony drug offenses to misdemeanors in 2014, on racial/ethnic disparities in drug…”
    Get full text
    Journal Article
  19. 19

    Hepatitis C mortality trends in San Francisco: can we reach elimination targets? by Mirzazadeh, Ali, Facente, Shelley N., Burk, Katie, Kahn, James G., Morris, Meghan D.

    Published in Annals of epidemiology (01-01-2022)
    “…Hepatitis C virus (HCV) is the most common blood-borne infection in the United States, and a leading cause of liver disease, transplant, and mortality. CDC HCV…”
    Get full text
    Journal Article
  20. 20